SummaryCDKL5 deficiency disorder is a rare genetic disease caused by mutations in the CDKL5 gene. Central apneas during wakefulness have been reported in patients with CDKL5 deficiency disorder. Studies on CDKL5‐knockout mice, a CDKL5 deficiency disorder model, reported sleep apneas, but it is still unclear whether these events are central (central sleep apnea) or obstructive (obstructive sleep apnea) and may be related to alterations of brain circuits that modulate breathing rhythm. This study aimed to discriminate central sleep apnea and obstructive sleep apnea in CDKL5‐knockout mice, and explore changes in the somatostatin neurons expressing high levels of neurokinin‐1 receptors within the preBötzinger complex. Ten adult male wild‐type and 12 CDKL5‐knockout mice underwent electrode implantation for sleep stage discrimination and diaphragmatic activity recording, and were studied using whole‐body plethysmography for 7 hr during the light (resting) period. Sleep apneas were categorised as central sleep apnea or obstructive sleep apnea based on the recorded signals. The number of somatostatin neurons in the preBötzinger complex and their neurokinin‐1 receptors expression were assessed through immunohistochemistry in a sub‐group of animals. CDKL5‐knockout mice exhibited a higher apnea occurrence rate and a greater prevalence of obstructive sleep apnea during rapid eye movement sleep, compared with wild‐type, whereas no significant difference was observed for central sleep apnea. Moreover, CDKL5‐knockout mice showed a reduced number of somatostatin neurons in the preBötzinger complex, and these neurons expressed a lower level of neurokinin‐1 receptors compared with wild‐type controls. These findings underscore the pivotal role of CDKL5 in regulating normal breathing, suggesting its potential involvement in shaping preBötzinger complex neural circuitry and controlling respiratory muscles during sleep.
